Genprex (GNPX) Capital Expenditures (2016 - 2021)

Genprex's Capital Expenditures history runs 6 years deep, the most recent figure standing at $11220.0 for Q4 2021.

• In Q4 2021, Capital Expenditures rose 269.69% year-over-year to $11220.0; the TTM figure through Sep 2022 stood at $11220.0 (down 52.29% YoY), while the FY2021 annual figure was $31700.0, up 80.48% from the prior year.
• Capital Expenditures for Q4 2021 stood at $11220.0, down from $11338.0 in the prior quarter.
• The five-year high for Capital Expenditures was $91701.0 in Q1 2021, with the low at -$82559.0 in Q2 2021.
• The 5-year median for Capital Expenditures is $3086.5 (2017), against an average of $5547.9.
• The sharpest annual moves came in 2018 and 2021: Capital Expenditures jumped 9657.8% in 2018, then sank 6215.48% in 2021.
• Genprex's Capital Expenditures stood at -$109.0 in 2017, then surged by 9657.8% to $10418.0 in 2018, then surged by 135.08% to $24491.0 in 2019, then tumbled by 87.61% to $3035.0 in 2020, then jumped by 269.69% to $11220.0 in 2021.
• Business Quant data shows GNPX's Capital Expenditures at $11220.0 in Q4 2021, $11338.0 in Q3 2021, and -$82559.0 in Q2 2021.